The contrasting oncogenic and tumor suppressor roles of FES

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 2, 2012, Pages 489-501

  Greer, Peter A ^a   Kanda, Shigeru ^b   Smithgall, Thomas E ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

F BAR; FES; FPS; Oncogene; Review; SH2; Transgenic; Tumor suppressor; Tyrosine kinase

Indexed keywords

CYCLIN D1; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; OXYGEN DERIVATIVE; PROLACTIN; PROTEIN CDC42; PROTEIN KINASE FES; SMALL INTERFERING RNA; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL INVASION; CELL SURVIVAL; CELL TRANSFORMATION; CIRCULATING TUMOR CELL; COLON CANCER; CRYSTAL STRUCTURE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; ENDOCYTOSIS; ENDOTHELIUM CELL; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; MEMBRANE BINDING; MISSENSE MUTATION; MOLONEY MURINE SARCOMA ONCOVIRUS; MYELOID LEUKEMIA; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSLATIONAL RESEARCH; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WOUND HEALING; ANIMAL; GENETICS; MOUSE; MUTATION; PROTO ONCOGENE; REVIEW; TRANSGENIC MOUSE;

MUS MUSCULUS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; PROTO-ONCOGENE PROTEINS C-FES; PROTO-ONCOGENES;

EID: 84860187756     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s280     Document Type: Article

References (116)

1. P. Greer, Closing in on the biological functions of Fps/Fes and Fer. Nat Rev Mol Cell Biol 3 278-289 (2002) (Pubitemid 34619263)
2. W. Sangrar, Craig, A. W., Greer, P. A, FES and FER: The F-BAR Domain-Containing Protein-Tyrosine Kinases, Landes Bioscience, (2008)
3. T. E. Smithgall, J. A. Rogers, K. L. Peters, J. Li, S. D. Briggs, J. M. Lionberger, H. Cheng, A. Shibata, B. Scholtz, S. Schreiner, and N. Dunham, The c-Fes family of proteintyrosine kinases. Crit Rev Oncog 9 43-62 (1998)
4. M. Shibuya, T. Hanafusa, H. Hanafusa, and J. R. Stephenson, Homology exists among the transforming sequences of avian and feline sarcoma viruses. Proc Natl Acad Sci U S A 77 6536-6540 (1980) (Pubitemid 11219163)
5. M. Shibuya, and H. Hanafusa, Nucleotide sequence of Fujinami sarcoma virus: evolutionary relationship of its transforming gene with transforming genes of other sarcoma viruses. Cell 30 787-95 (1982) (Pubitemid 13204664)
6. C. J. Sherr, L. A. Fedele, M. Oskarsson, J. Maizel, and G. V. Woude, Molecular cloning of Snyder-Theilen feline leukemia and sarcoma viruses: comparative studies of feline sarcoma virus with its natural helper virus and with Moloney murine sarcoma virus. J Virol 34 200-212 (1980) (Pubitemid 10149396)
7. G. Franchini, J. Even, C. J. Sherr, and F. Wong-Staal, onc sequences (v-fes) of Snyder-Theilen feline sarcoma virus are derived from noncontiguous regions of a cat cellular gene (c-fes). Nature 290 154-157 (1981) (Pubitemid 11149694)
8. A. Hampe, I. Laprevotte, F. Galibert, L. A. Fedele, and C. J. Sherr, Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes. Cell 30 775-785 (1982)
9. M. Barbacid, Cellular transformation by subgenomic feline sarcoma virus DNA. J Virol 37 518-523 (1981) (Pubitemid 11174624)
10. D. A. Foster, and H. Hanafusa, A fps gene without gag gene sequences transforms cells in culture and induces tumors in chickens. J Virol 48 744-751 (1983) (Pubitemid 14232286)
11. S. P. Yee, D. Mock, P. Greer, V. Maltby, J. Rossant, A. Bernstein, and T. Pawson, Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps proteintyrosine kinase. Mol Cell Biol 9 5491-5499 (1989) (Pubitemid 20004367)
12. S. P. Yee, D. Mock, V. Maltby, M. Silver, J. Rossant, A. Bernstein, and T. Pawson, Cardiac and neurological abnormalities in v-fps transgenic mice. Proc Natl Acad Sci U S A 86 5873-5877 (1989) (Pubitemid 19217551)
13. D. Stehelin, H. E. Varmus, J. M. Bishop, and P. K. Vogt, DNA related to the transforming gene (s) of avian sarcoma viruses is present in normal avian DNA. Nature 260 170-173 (1976)
14. J. Groffen, N. Heisterkamp, F. Grosveld, W. Van de Ven, and J. R. Stephenson, Isolation of human oncogene sequences (v-fes homolog) from a cosmid library. Science 216 1136-1138 (1982) (Pubitemid 12063278)
15. J. Groffen, N. Heisterkamp, M. Shibuya, H. Hanafusa, and J. R. Stephenson, Transforming genes of avian (v-fps) and mammalian (v-fes) retroviruses correspond to a common cellular locus. Virology 125 480-486 (1983) (Pubitemid 13120124)
16. A. J. Roebroek, J. A. Schalken, J. S. Verbeek, A. M. Van den Ouweland, C. Onnekink, H. P. Bloemers, and W. J. Van de Ven, The structure of the human c-fes/fps protooncogene. Embo J 4 2897-2903 (1985)
17. C. C. Huang, C. Hammond, and J. M. Bishop, Nucleotide sequence and topography of chicken c-fps. Genesis of a retroviral oncogene encoding a tyrosinespecific protein kinase. J Mol Biol 181 175-186 (1985)
18. J. C. Stone, T. Atkinson, M. Smith, and T. Pawson, Identification of functional regions in the transforming protein of Fujinami sarcoma virus by in-phase insertion mutagenesis. Cell 37 549-558 (1984) (Pubitemid 14079049)
19. I. Sadowski, J. C. Stone, and T. Pawson, A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol Cell Biol 6 4396-4408 (1986) (Pubitemid 17217381)
20. J. E. DeClue, I. Sadowski, G. S. Martin, and T. Pawson, A conserved domain regulates interactions of the v-fps protein-tyrosine kinase with the host cell. Proc Natl Acad Sci U S A 84 9064-9068 (1987)
21. M. L. Stahl, C. R. Ferenz, K. L. Kelleher, R. W. Kriz, and J. L. Knopf, Sequence similarity of phospholipase C with the non-catalytic region of src. Nature 332 269-272 (1988) (Pubitemid 18076659)
22. M. Trahey, G. Wong, R. Halenbeck, B. Rubinfeld, G. A. Martin, M. Ladner, C. M. Long, W. J. Crosier, K. Watt, K. Koths, and et al., Molecular cloning of two types of GAP complementary DNA from human placenta. Science 242 1697-1700 (1988) (Pubitemid 19022176)
23. U. S. Vogel, R. A. Dixon, M. D. Schaber, R. E. Diehl, M. S. Marshall, E. M. Scolnick, I. S. Sigal, and J. B. Gibbs, Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 335 90-93 (1988)
24. A. Kazlauskas, and J. A. Cooper, Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 58 1121-1133 (1989) (Pubitemid 19238189)
25. C. Ellis, M. Moran, F. McCormick, and T. Pawson, Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 343 377-381 (1990)
26. D. Anderson, C. A. Koch, L. Grey, C. Ellis, M. F. Moran, and T. Pawson, Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. Science 250 979-982 (1990) (Pubitemid 120031802)
27. M. F. Moran, C. A. Koch, D. Anderson, C. Ellis, L. England, G. S. Martin, and T. Pawson, Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci U S A 87 8622-8626 (1990)
28. C. A. Koch, D. Anderson, M. F. Moran, C. Ellis, and T. Pawson, SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252 668-674 (1991) (Pubitemid 21916987)
29. G. Waksman, D. Kominos, S. C. Robertson, N. Pant, D. Baltimore, R. B. Birge, D. Cowburn, H. Hanafusa, B. J. Mayer, M. Overduin, M. D. Resh, C. B. Rios, L. Silverman, and J. Kuriyan, Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosinephosphorylated peptides. Nature 358 646-653 (1992)
30. B. A. Liu, K. Jablonowski, M. Raina, M. Arce, T. Pawson, and P. D. Nash, The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol Cell 22 851-868 (2006)
31. K. Machida, C. M. Thompson, K. Dierck, K. Jablonowski, S. Karkkainen, B. Liu, H. Zhang, P. D. Nash, D. K. Newman, P. Nollau, T. Pawson, G. H. Renkema, K. Saksela, M. R. Schiller, D. G. Shin, and B. J. Mayer, High throughput phosphotyrosine profiling using SH2 domains. Mol Cell 26 899-915 (2007) (Pubitemid 46929095)
32. H. Huang, L. Li, C. Wu, D. Schibli, K. Colwill, S. Ma, C. Li, P. Roy, K. Ho, Z. Songyang, T. Pawson, Y. Gao, and S. S. Li, Defining the specificity space of the human SRC homology 2 domain. Mol Cell Proteomics 7 768-784 (2008) (Pubitemid 351597486)
33. T. Pawson, Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116 191-203 (2004) (Pubitemid 38167312)
34. C. A. Koch, M. Moran, I. Sadowski, and T. Pawson, The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function. Mol Cell Biol 9 4131-4140 (1989) (Pubitemid 19239582)
35. Z. Songyang, S. E. Shoelson, J. McGlade, P. Olivier, T. Pawson, X. R. Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, T. Yi, and et al., Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 14 2777-2785 (1994)
36. P. Filippakopoulos, M. Kofler, O. Hantschel, G. D. Gish, F. Grebien, E. Salah, P. Neudecker, L. E. Kay, B. E. Turk, G. Superti-Furga, T. Pawson, and S. Knapp, Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell 134 793-803 (2008)
37. I. Sadowski, and T. Pawson, Catalytic and noncatalytic domains of the Fujinami sarcoma virus P130gagfps protein-tyrosine kinase distinguished by the expression of v-fps polypeptides in Escherichia coli. Oncogene 1 181-191 (1987) (Pubitemid 17144621)
38. P. Aspenstrom, A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton. Curr Biol 7 479-487 (1997) (Pubitemid 27308971)
39. V. A. McPherson, S. Everingham, R. Karisch, J. A. Smith, C. M. Udell, J. Zheng, Z. Jia, and A. W. Craig, Contributions of F-BAR and SH2 domains of Fes protein tyrosine kinase for coupling to the FcepsilonRI pathway in mast cells. Mol Cell Biol 29 389-401 (2009)
40. S. Suetsugu, K. Toyooka, and Y. Senju, Subcellular membrane curvature mediated by the BAR domain superfamily proteins. Semin Cell Dev Biol 21 340-349 (2010)
41. K. Tsujita, S. Suetsugu, N. Sasaki, M. Furutani, T. Oikawa, and T. Takenawa, Coordination between the actin cytoskeleton and membrane deformation by a novel membrane tubulation domain of PCH proteins is involved in endocytosis. J Cell Biol 172 269-279 (2006) (Pubitemid 43112973)
42. W. M. Henne, E. Boucrot, M. Meinecke, E. Evergren, Y. Vallis, R. Mittal, and H. T. McMahon, FCHo proteins are nucleators of clathrin-mediated endocytosis. Science 328 1281-1284 (2010)
43. V. Chitu, and E. R. Stanley, Pombe Cdc15 homology (PCH) proteins: coordinators of membrane-cytoskeletal interactions. Trends Cell Biol 17 145-156 (2007) (Pubitemid 46341827)
44. Y. Rao, Q. Ma, A. Vahedi-Faridi, A. Sundborger, A. Pechstein, D. Puchkov, L. Luo, O. Shupliakov, W. Saenger, and V. Haucke, Molecular basis for SH3 domain regulation of F-BAR-mediated membrane deformation. Proc Natl Acad Sci U S A 107 8213-8218 (2010)
45. W. M. Henne, E. Boucrot, M. Meinecke, E. Evergren, Y. Vallis, R. Mittal, and H. T. McMahon, FCHo proteins are nucleators of clathrin-mediated endocytosis. Science 328 1281-1284 (2010)
46. A. Sorkin, and M. von Zastrow, Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 10 609-622 (2009)
47. S. A. Parsons, and P. A. Greer, The Fps/Fes kinase regulates the inflammatory response to endotoxin through down-regulation of TLR4, NF-kappaB activation, and TNF-alpha secretion in macrophages. J Leukoc Biol 80 1522-1528 (2006) (Pubitemid 44904991)
48. S. A. Parsons, J. D. Mewburn, P. Truesdell, and P. A. Greer, The Fps/Fes kinase regulates leucocyte recruitment and extravasation during inflammation. Immunology 122 542-550 (2007) (Pubitemid 350075950)
49. R. A. Zirngibl, Y. Senis, and P. A. Greer, Enhanced endotoxin sensitivity in fps/fes-null mice with minimal defects in hematopoietic homeostasis. Mol Cell Biol 22 2472-2486 (2002) (Pubitemid 34262970)
50. B. A. Ballif, G. R. Carey, S. R. Sunyaev, and S. P. Gygi, Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain. J Proteome Res 7 311-318 (2008) (Pubitemid 351171145)
51. J. F. Cote, P. L. Chung, J. F. Theberge, M. Halle, S. Spencer, L. A. Lasky, and M. L. Tremblay, PSTPIP is a substrate of PTP-PEST and serves as a scaffold guiding PTP-PEST toward a specific dephosphorylation of WASP. J Biol Chem 277 2973-2986 (2002) (Pubitemid 34953333)
52. C. Jorgensen, A. Sherman, G. I. Chen, A. Pasculescu, A. Poliakov, M. Hsiung, B. Larsen, D. G. Wilkinson, R. Linding, and T. Pawson, Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science 326 1502-1509 (2009)
53. P. Aspenstrom, Roles of F-BAR/PCH proteins in the regulation of membrane dynamics and actin reorganization. Int Rev Cell Mol Biol 272 1-31 (2009)
54. S. Guerrier, J. Coutinho-Budd, T. Sassa, A. Gresset, N. V. Jordan, K. Chen, W. L. Jin, A. Frost, and F. Polleux, The F-BAR domain of srGAP2 induces membrane protrusions required for neuronal migration and morphogenesis. Cell 138 990-1004 (2009)
55. A. Hall, Rho GTPases and the actin cytoskeleton. Science 279 509-514 (1998) (Pubitemid 28067271)
56. A. J. Ridley, Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16 522-529 (2006) (Pubitemid 44444995)
57. J. Li, and T. E. Smithgall, Fibroblast transformation by Fps/Fes tyrosine kinases requires Ras, Rac, and Cdc42 and induces extracellular signal-regulated and c-Jun. N-terminal kinase activation. J Biol Chem 273 13828-13834 (1998) (Pubitemid 28268433)
58. C. E. Laurent, and T. E. Smithgall, The c-Fes tyrosine kinase cooperates with the breakpoint cluster region protein (Bcr) to induce neurite extension in a Rac-and Cdc42-dependent manner. Exp Cell Res 299 188-198 (2004) (Pubitemid 39078394)
59. Z. Shapovalova, K. Tabunshchyk, and P. A. Greer, The Fer tyrosine kinase regulates an axon retraction response to Semaphorin 3A in dorsal root ganglion neurons. BMC Dev Biol 7 133-146 (2007)
60. S. Wasiak, C. C. Quinn, B. Ritter, E. de Heuvel, D. Baranes, M. Plomann, and P. S. McPherson, The Ras/Rac guanine nucleotide exchange factor mammalian Son-ofsevenless interacts with PACSIN 1/syndapin I, a regulator of endocytosis and the actin cytoskeleton. J Biol Chem 276 26622-26628 (2001)
61. R. A. Feldman, J. L. Gabrilove, J. P. Tam, M. A. Moore, and H. Hanafusa, Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells. Proc Natl Acad Sci U S A 82 2379-83 (1985) (Pubitemid 15064491)
62. I. MacDonald, J. Levy, and T. Pawson, Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein. Mol Cell Biol 5 2543-2551 (1985) (Pubitemid 15249538)
63. S. Ferrari, A. Donelli, R. Manfredini, M. Sarti, R. Roncaglia, E. Tagliafico, E. Rossi, G. Torelli, and U. Torelli, Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells. Cell Growth Differ 1 543-548 (1990)
64. J. M. Lionberger, and T. E. Smithgall, The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl. Cancer Res 60 1097-103 (2000) (Pubitemid 30129551)
65. R. Manfredini, A. Grande, E. Tagliafico, D. Barbieri, P. Zucchini, G. Citro, G. Zupi, C. Franceschi, U. Torelli, and S. Ferrari, Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation. J Exp Med 178 381-389 (1993) (Pubitemid 23218186)
66. J. A. Rogers, H. Y. Cheng, and T. E. Smithgall, Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase. Cell Growth Differ 11 581-592 (2000)
67. G. Yu, T. E. Smithgall, and R. I. Glazer, K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation. J Biol Chem 264 10276-10281 (1989) (Pubitemid 19159301)
68. P. Greer, V. Maltby, J. Rossant, A. Bernstein, and T. Pawson, Myeloid expression of the human c-fps/fes protooncogene in transgenic mice. Mol Cell Biol 10 2521-2527 (1990)
69. P. Greer, J. Haigh, G. Mbamalu, W. Khoo, A. Bernstein, and T. Pawson, The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol Cell Biol 14 6755-6763 (1994) (Pubitemid 24299745)
70. W. Sangrar, Y. Gao, R. A. Zirngibl, M. L. Scott, and P. A. Greer, The fps/fes proto-oncogene regulates hematopoietic lineage output. Exp Hematol 31 1259-1267 (2003) (Pubitemid 37510032)
71. W. Sangrar, J. D. Mewburn, S. G. Vincent, J. T. Fisher, and P. A. Greer, Vascular defects in gain-of-function fps/fes transgenic mice correlate with PDGF-and VEGF-induced activation of mutant Fps/Fes kinase in endothelial cells. J Thromb Haemost 2 820-832 (2004) (Pubitemid 40185720)
72. W. Sangrar, Y. Senis, J. A. Samis, Y. Gao, M. Richardson, D. H. Lee, and P. A. Greer, Hemostatic and hematological abnormalities in gain-of-function fps/fes transgenic mice are associated with the angiogenic phenotype. J Thromb Haemost 2 2009-2019 (2004) (Pubitemid 40192755)
73. D. S. Kaufman, E. T. Hanson, R. L. Lewis, R. Auerbach, and J. A. Thomson, Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 98 10716-10721 (2001) (Pubitemid 32878687)
74. L. S. Lu, S. J. Wang, and R. Auerbach, In vitro and in vivo differentiation into B cells, T cells, and myeloid cells of primitive yolk sac hematopoietic precursor cells expanded gt; 100-fold by coculture with a clonal yolk sac endothelial cell line. Proc Natl Acad Sci U S A 93 14782-14787 (1996)
75. S. J. Wang, P. Greer, and R. Auerbach, Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-offunction fps/fes proto-oncogene. In vitro Cell Dev Biol Anim 32 292-299 (1996)
76. S. Kanda, H. Kanetake, and Y. Miyata, Downregulation of Fes inhibits VEGF-A-induced chemotaxis and capillary-like morphogenesis by cultured endothelial cells. J Cell Mol Med 11 495-501 (2007) (Pubitemid 47153459)
77. S. Kanda, E. C. Lerner, S. Tsuda, T. Shono, H. Kanetake, and T. E. Smithgall, The nonreceptor protein tyrosine kinase c-Fes is involved in fibroblast growth factor-2-induced chemotaxis of murine brain capillary endothelial cells. J Biol Chem 275 10105-10111 (2000) (Pubitemid 30202062)
78. J. J. Haigh, M. Ema, K. Haigh, M. Gertsenstein, P. Greer, J. Rossant, A. Nagy, and E. F. Wagner, Activated Fps/Fes partially rescues the in vivo developmental potential of Flk1-deficient vascular progenitor cells. Blood 103 912-920 (2004) (Pubitemid 38129550)
79. S. Kanda, Y. Miyata, Y. Mochizuki, T. Matsuyama, and H. Kanetake, Angiopoietin 1 is mitogenic for cultured endothelial cells. Cancer Res 65 6820-6827 (2005) (Pubitemid 41060720)
80. Y. Senis, R. Zirngibl, J. McVeigh, A. Haman, T. Hoang, and P. A. Greer, Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis. Mol Cell Biol 19 7436-7446 (1999) (Pubitemid 29493407)
81. R. Hackenmiller, J. Kim, R. A. Feldman, and M. C. Simon, Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/-mice. Immunity 13 397-407 (2000)
82. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani, Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30 1073-1081 (2009)
83. A. Bardelli, D. W. Parsons, N. Silliman, J. Ptak, S. Szabo, S. Saha, S. Markowitz, J. K. Willson, G. Parmigiani, K. W. Kinzler, B. Vogelstein, and V. E. Velculescu, Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300 949 (2003) (Pubitemid 36548874)
84. W. Sangrar, R. A. Zirgnibl, Y. Gao, W. J. Muller, Z. Jia, and P. A. Greer, An identity crisis for fps/fes: oncogene or tumor suppressor? Cancer Res 65 3518-3522 (2005) (Pubitemid 40616322)
85. P. F. Truesdell, R. A. Zirngibl, S. Francis, W. Sangrar, and P. A. Greer, fps/fes knockout mice display a lactation defect and the fps/fes tyrosine kinase is a component of Ecadherinbased adherens junctions in breast epithelial cells during lactation. Exp Cell Res 315 2929-2940 (2009)
86. F. J. Delfino, H. Stevenson, and T. E. Smithgall, A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer. J Biol Chem 281 8829-8835 (2006) (Pubitemid 43847989)
87. J. M. Shaffer, and T. E. Smithgall, Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer. Genes Chromosomes Cancer 48 272-284 (2009)
88. H. F. Karthaus, J. A. Schalken, W. F. Feitz, F. M. Debruyne, P. T. de Haan, H. P. Bloemers, and W. J. Van de Ven, Expression of the human fes cellular oncogene in renal cell tumors. Urol Res 14 123-127 (1986) (Pubitemid 16090996)
89. S. Kanda, Y. Miyata, H. Kanetake, and T. E. Smithgall, Downregulation of the c-Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells.. Int J Oncol 34 89-96 (2009)
90. F. R. Greten, L. Eckmann, T. F. Greten, J. M. Park, Z. W. Li, L. J. Egan, M. F. Kagnoff, and M. Karin, IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 285-296 (2004) (Pubitemid 39061110)
91. S. Zhang, V. Chitu, E. R. Stanley, B. E. Elliott, and P. A. Greer, Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis and infiltrating macrophages. Cancer Res 71 1465-1473 (2011)
92. D. Hanahan, and R. A. Weinberg, The hallmarks of cancer. Cell 100 57-70 (2000) (Pubitemid 30046295)
93. Y. A. Senis, W. Sangrar, R. A. Zirngibl, A. W. Craig, D. H. Lee, and P. A. Greer, Fps/Fes and Fer non-receptor protein-tyrosine kinases regulate collagen-and ADPinduced platelet aggregation. J Thromb Haemost 1 1062-1070 (2003)
94. C. M. Udell, L. A. Samayawardhena, Y. Kawakami, T. Kawakami, and A. W. Craig, Fer and Fps/Fes participate in a Lyn-dependent pathway from FcepsilonRI to plateletendothelial cell adhesion molecule 1 to limit mast cell activation. J Biol Chem 281 20949-20957 (2006) (Pubitemid 44115436)
95. A. W. Craig, and P. A. Greer, Fer kinase is required for sustained p38 kinase activation and maximal chemotaxis of activated mast cells. Mol Cell Biol 22 6363-6374 (2002)
96. K. Izuhara, R. A. Feldman, P. Greer, and N. Harada, Interleukin-4 induces association of the c-fes protooncogene product with phosphatidylinositol-3 kinase. Blood 88 3910-3918 (1996) (Pubitemid 26383115)
97. L. Lanfrancone, P. Mannoni, M. J. Pebusque, A. Care, C. Peschle, F. Grignani, and P. G. Pelicci, Expression pattern of c-fes oncogene mRNA in human myeloid cells. Int J Cancer Suppl 4 35-38 (1989) (Pubitemid 19283173)
98. T. E. Smithgall, G. Yu, and R. I. Glazer, Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells. J Biol Chem 263 15050-15055 (1988)
99. J. Condeelis, and J. W. Pollard, Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124 263-266 (2006) (Pubitemid 43121975)
100. E. Y. Lin, and J. W. Pollard, Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67 5064-5066 (2007) (Pubitemid 46997238)
101. J. B. Wyckoff, Y. Wang, E. Y. Lin, J. F. Li, S. Goswami, E. R. Stanley, J. E. Segall, J. W. Pollard, and J. Condeelis, Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67 2649-2656 (2007) (Pubitemid 46548952)
102. A. Patsialou, J. Wyckoff, Y. Wang, S. Goswami, E. R. Stanley, and J. S. Condeelis, Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res 69 9498-9506 (2009)
103. B. D. Robinson, G. L. Sica, Y. F. Liu, T. E. Rohan, F. B. Gertler, J. S. Condeelis, and J. G. Jones, Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 15 2433-2441 (2009)
104. J. Kim, and R. A. Feldman, Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1. Mol Cell Biol 22 1903-1918 (2002) (Pubitemid 34175005)
105. J. Kim, Y. Ogata, and R. A. Feldman, Fes tyrosine kinase promotes survival and terminal granulocyte differentiation of factor-dependent myeloid progenitors (32D) and activates lineage-specific transcription factors. J Biol Chem 278 14978-14984 (2003) (Pubitemid 36799829)
106. F. O. Martinez, L. Helming, and S. Gordon, Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27 451-483 (2009)
107. F. Balkwill, K. A. Charles, and A. Mantovani, Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7 211-217 (2005) (Pubitemid 40568680)
108. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, Cancer-related inflammation. Nature 454 436-444 (2008)
109. H. Jiang, K. Foltenyi, M. Kashiwada, L. Donahue, B. Vuong, B. Hehn, and P. Rothman, Fes mediates the IL-4 activation of insulin receptor substrate-2 and cellular proliferation. J Immunol 166 2627-2634 (2001) (Pubitemid 32173501)
110. K. Izuhara, R. A. Feldman, P. Greer, and N. Harada, Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. J Biol Chem 269 18623-18629 (1994) (Pubitemid 24224103)
111. I. Roodink, and W. P. Leenders, Targeted therapies of cancer: angiogenesis inhibition seems not enough. Cancer Lett 299 1-10 (2010)
112. S. Lord, and A. L. Harris, Angiogenesis - still a worthwhile target for breast cancer therapy? Breast Cancer Res 12, Suppl 4 S19 (2010)
113. P. A. Nguewa, A. Calvo, S. S. Pullamsetti, G. A. Banat, F. Grimminger, and R. Savai, Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of nonsmall cell lung cancer. Expert Opin Investig Drugs 20 61-74 (2011)
114. M. Paez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Vinals, M. Inoue, G. Bergers, D. Hanahan, and O. Casanovas, Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15 220-231 (2009)
115. J. M. Ebos, C. R. Lee, W. Cruz-Munoz, G. A. Bjarnason, J. G. Christensen, and R. S. Kerbel, Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15 232-239 (2009)
116. T. Itoh, J. Hasegawa, K. Tsujita, Y. Kanaho, and T. Takenawa, The tyrosine kinase Fer is a downstream target of the PLD-PA pathway that regulates cell migration. Sci Signal 2, ra52 (2009)